Elro Pharma

1 clinical trials · Sponsor

Record	Firm	Date
Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors (NCT01711398)	Elro Pharma	2012-07-01

Every clearance here is in the API, with alerts when new ones post.